Concepedia

European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed

Georgios Schoretsanitis, Robert L. Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, I. Cánovas Olmos, Marta Vázquez, Celso Iglesias García,

Journal of Clinical Psychopharmacology · 2021 · 29 citations · 42 references

DOI

Abstract

Our recommended dosages are less than those recommended in Europe. Future studies in European Whites need to replicate these recommended doses for average metabolizer patients after sex and smoking stratification and further explore clozapine dosing for those with relevant clinical confounders.

References

42

Serious Adverse Drug Events Reported to the Food and Drug Administration, 1998-2005

Thomas J. Moore · Archives of Internal Medicine · 2007 · 458 citations

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

Leif Bertilsson, JA Carrillo, M-L Dahl et al. · British Journal of Clinical Pharmacology · 1994 · 306 citations · Full text

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

Markus Jerling, Leif Lindström, Ulf Bondesson et al. · Therapeutic Drug Monitoring · 1994 · 279 citations

, , +13

Influence of Dose, Cigarette Smoking, Age, Sex, and Metabolic Activity on Plasma Clozapine Concentrations

Amin Rostami‐Hodjegan, Ajmal M. Amin, Edgar P. Spencer et al. · Journal of Clinical Psychopharmacology · 2004 · 266 citations

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

Roza Ghotbi, Magnus Christensen, Hyung‐Keun Roh et al. · European Journal of Clinical Pharmacology · 2007 · 262 citations

, , +10